RxDoctor Payments Data

Jean Kernal

Adult Health · Morgantown, WVNPI 1972880946

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,300 of the $5,567 with a category attached, or 77.2%. Salix Pharmaceuticals, A Division Of Bausch Health US, LLC accounts for 92.6% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $5,265, more than ten times the $16 reported in 2021. Among adult health clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,567in general payments, 2019–2025

Across 31 payments — averaging $179.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$5K
  • AbbVie$309
  • Takeda Pharmaceuticals U.S.A., Inc.$36
  • Mallinckrodt Hospital Products Inc.$24
  • Abbott$23
  • Intercept Pharmaceuticals, Inc.$21

What the payments were for

  • Speaking & faculty fees$4,30077%
  • Travel & lodging$4238%
  • Food & beverage$84415%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,567 in reported general payments places this provider in the 95th percentile of 30 adult health providers in West Virginia.

See all adult health providers in West Virginia

Medicare billing

Part B allowed, 2024
$18,901
Medicare patients
157
Services billed
232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin159$523,627
Ursodiol45$5,931
Esomeprazole Magnesium16$4,447
Spironolactone125$1,780
Lactulose73$1,358
Tacrolimus28$1,081
Azathioprine30$769
Entecavir15$708
Pantoprazole Sodium51$707
ConstuloseLactulose24$587
Famotidine30$470
Furosemide102$450
Omeprazole27$439
Propranolol Hcl24$401
Amiloride Hcl16$380

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$5,154$523,627159 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 30 adult health providers in West Virginia.

Other adult health in Morgantown

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →